Kronos Advanced Technologies Inc. manufactures, distributes, and licenses air movement and purification devices in the United States. The company offers air purifiers and masks. It markets and sells ...

A positive clinical trial is usually a signal for a biotech startup to press the accelerator on its spending, but Kronos Bio is taking a different tack. The Californian biotech is axing 19% of its ...

For more than 40 years, the Kronos Quartet—David Harrington (violin), John Sherba (violin), Hank Dutt (viola), and Sunny Yang (cello)—has pursued a singular artistic vision, combining a spirit of ...

Git isn't hard to learn, and when you combine Git and GitHub, you've just made the learning process significantly easier. This two-hour Git and GitHub video tutorial shows you how to get started with ...

We rarely invite the same band back to the Tiny Desk. But the beloved Kronos Quartet, which first played our offices 12 years ago, isn't the same band. Three of the four members are brand new: Cellist ...

Korg has expanded its catalogue of virtual instruments with the release of Collection 6, a newly-updated version of its suite of software recreations of classic Korg synths. Korg launched its Legacy ...

UK-based Ignota Labs has acquired all of the clinical-stage assets in Kronos Bio's pipeline, after the US company ceased operations earlier this year. Ignota specialises in turning around promising ...

The new Kronos IEMs from have nine drivers and a six-way crossover but an impedance of less than 35Ω. Noble Audio has announced the launch of its latest pair of flagship in-ear monitors. The Kronos ...

Today (July 16) marks the 80th anniversary of the Trinity test, during which a team of U.S. scientists led by J. Robert Oppenheimer detonated the world’s first atomic bomb in the deserts of New Mexico ...

Get exclusive reporting, live Q&As and ad-free reading. It’s a question Asa Chandler hasn’t stopped asking since he heard his old friend Tony Kronos was missing. The 40-year-old was last seen at his ...

Concentra Biosciences inked a definitive deal to acquire Kronos Bio’s common stock for 57 cents per share. (cagkansayin/GettyImages) With the walls quickly closing ...

CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. ("Kronos Bio") (Nasdaq: KRON), a biotechnology company that has been developing small molecule therapeutics to address cancers and ...